NFKB1 and familial pancreatic carcinoma: A previous study also found that emodin could down-regulate the expression of NF-κB and NF-κB-regulated proteins, such as eNOS, and could reduce eNOS phosphorylation in orthotopic pancreatic cancer tissues [41].